Sabharwal, Ami <br/><br/>
Predicting the myelotoxicity of chemotherapy:  the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells.  [electronic resource] 

 -  Melanoma research  Dec 2011 
 - 502-8 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5636 
<br/><br/><label>Standard No.: </label>10.1097/CMR.0b013e32832ccd58  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Pharmacological--analysis<br/>Dacarbazine--administration & dosage<br/>Drug Administration Routes<br/>Drug Administration Schedule<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Leukocytes, Mononuclear--drug effects<br/>Myeloid Cells--drug effects<br/>O(6)-Methylguanine-DNA Methyltransferase--analysis<br/>Predictive Value of Tests<br/>Prognosis<br/>Recombinant Proteins--administration & dosage<br/>Retrospective Studies<br/>Temozolomide<br/>Thalidomide--administration & dosage<br/>Time Factors